Skip to search formSkip to main contentSkip to account menu

Metformin

Known as: Metformine, Dimethylbiguanid, Imidodicarbonimidic diamide, N,N-dimethyl- 
An agent belonging to the biguanide class of antidiabetics with antihyperglycemic activity. Metformin is associated with a very low incidence of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Monocyte-to-macrophage differentiation is a critical event that accentuates atherosclerosis by promoting an inflammatory… 
Highly Cited
2013
Highly Cited
2013
Purpose: Tumor hypoxia is a negative prognostic factor in multiple cancers, due in part to its role in causing resistance to… 
Review
2012
Review
2012
Departments of Genetics, Bioengineering, Stanford University Medical Center, Stanford University, Stanford and Department of… 
Review
2012
Review
2012
OBJECTIVE Oral antidiabetic drugs (including metformin and sulfonylurea) may play a role in the relationship between type 2… 
Highly Cited
2011
Highly Cited
2011
Metformin is the most widely used antidiabetic drug because of its proven efficacy and limited secondary effects. Interestingly… 
Highly Cited
2011
Highly Cited
2011
Purpose: Metformin is a widely used antidiabetic drug whose anticancer effects, mediated by the activation of AMP-activated… 
Highly Cited
2009
Highly Cited
2009
Organic cation transporters (OCTs) can mediate metformin transmembrane transport. We explored metformin pharmacokinetics in… 
Highly Cited
2008
Highly Cited
2008
Studies in mammals have led to the suggestion that hyperglycemia and hyperinsulinemia are important factors both in aging and in… 
Highly Cited
2004
Highly Cited
2004
The antidiabetic drug metformin stimulates AMP-activated protein kinase (AMPK) activity in the liver and in skeletal muscle. To… 
Review
1996
Review
1996
SummaryThe biguanide metformin (dimethylbiguanide) is an oral antihyperglycaemic agent widely used in the management of non…